Does depression decrease the moderating effect of self‐efficacy in the relationship between illness perception and fear of progression in breast cancer?

Shim, Eun‐Jung; Lee, Jong Won; Min, Yul Ha

doi:10.1002/pon.4532

Cited by 25 publications

(20 citation statements)

References 39 publications

(105 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with our findings, illness perception positively associated with fear of progression (Shim et al, 2018). As the disease progresses, the exacerbation of patients' symptoms, the increase in economic cost and the accumulation of side effects will cause psychological, physiological and social impacts on patients (Maqhuzu et al, 2020; Yuan et al, 2019).…”

Section: Discussionsupporting

confidence: 93%

Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross‐sectional study

Liu

Qin

et al. 2021

Journal of Clinical Nursing

View full text Add to dashboard Cite

Aims and objectives:This study aimed to investigate whether fear of progression mediates the association between illness perception and quality of life among interstitial lung disease patients.Background: So far, the physiological treatment of interstitial lung disease is limited.In addition to immunosuppressants such as glucocorticoids, two anti-fibrosis drugs (pirfenidone and nintedanib) have shown moderately beneficial effects on slowing the progression of interstitial lung disease fibrosis. However, none of these drugs has shown reliable or strong beneficial effects on improving quality of life. Psychological care and mental health support strategies focusing on improving patients' quality of life are particularly important. Design: A cross-sectional study.Methods: A convenience sample of patients suffering from interstitial lung disease were enrolled from August to December 2019. Data including sociodemographic and clinical characteristics, illness perception, fear of progression and quality of life were collected. The descriptive analysis and Pearson correlations were analysed by SPSS 26.0 (IBM Corp.). PROCESS v3.4 (by Andrew F. Hayes) macro was applied to analyse the mediating effects. We used the STROBE checklist to report the results.Results: Both illness perception and fear of progression were correlated with quality of life. Fear of progression mediated the association between illness perception and quality of life. The indirect effect was 0.121, and the proportion of intermediary effect in the main effect was 26.36%. Conclusion:Interstitial lung disease patients experience relatively poor quality of life and fear of progression exerts a mediating role between illness perception and quality of life. Relevance to clinical practice:This study alerts medical staff to pay attention to negative illness perception and excessive fear, which is helpful to formulate effective interventions to manage interstitial lung disease patients' quality of life.

show abstract

Section: Discussionsupporting

confidence: 93%

Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross‐sectional study

Liu

Qin

et al. 2021

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…In a study conducted in New Zealand, on postmenopausal women with breast cancer undergoing chemotherapy, was reported a signi cant correlation between the worry of cancer recurrence and all domains of illness perception except personal control (26). Shim et al (2018) in an investigation among women with breast cancer in Korea reported that illness perception is a determinant of worry of cancer recurrence, and noted self-e cacy and depression as the moderators of the relationship between the illness perception and the worry of cancer recurrence (27). In another study on Japanese and Scandinavian women, the illness perception was signi cantly associated with the worry about cancer recurrence (28).…”

Section: Discussionmentioning

confidence: 99%

Predictors of the Worry About Cancer Recurrence Among Women With Breast Cancer

Safdari-Molan

Mehrabi

Nourizadeh

et al. 2021

Preprint

View full text Add to dashboard Cite

Introduction: Worry about cancer recurrence is identified as the most common psychological burdens experienced by cancer patients and survivors. The present study aimed to determine the predictors of worry about cancer recurrence among women with breast cancer. Materials and methods: This cross-sectional study was conducted on 166 women with breast cancer undergoing chemotherapy and radiotherapy, who referred to private and public oncology centers in Tabriz, Iran using the convenience sampling method. Data collection tools were demographic and disease characteristics questionnaire, cancer worry scale, social support questionnaire, brief illness perception questionnaire, international physical activity questionnaire-short form, and The EORTC-in-patsat32. The data were analyzed using SPSS 25 software. Pearson correlation coefficient, independent t-test, ANOVA, and multivariate linear regression were used.Results: In the present study, the mean (standard deviation) of score of worry about cancer recurrence was 17.41 (7.88) from the range of 8-32. The results revealed that the type of surgery, illness perception, satisfaction with care, and place of treatment were the most important predictors of worry about cancer recurrence, which explained 44.3% of the variance.Conclusion: The enhancement of satisfaction with care and training coping strategies among individuals with high perceived severity of the illness contribute to the reduction of worry about cancer recurrence and adaptation to breast cancer.

show abstract

“…Depressive moods might affect a person’s belief to accomplish a desired behaviour or to achieve a target outcome (self-efficacy) 56. To control for the emotional state of the patients, we added a one-item Visual Analogue Scale on mood asking ‘how do you rate your mood during the last two weeks?’ 57…”

Section: Methods and Analysismentioning

confidence: 99%

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Bana

Ribi

Kropf-Staub³

et al. 2019

BMJ Open

View full text Add to dashboard Cite

IntroductionSelf-management interventions show promising results on symptom outcomes and self-management behaviours. The Symptom Navi© Programme (SN©P) is a nurse-led intervention supporting patients’ symptom self-management during anticancer treatment. It consists of written patient information (Symptom Navi© Flyers (SN©Flyers)), semistructured consultations and a training manual for nurses.Methods and analysisThis pilot study will evaluate the implementation of the SN©P based on the Reach Effectiveness—Adoption Implementation Maintenance framework at Swiss outpatient cancer centres. We will use a cluster-randomised design and randomise the nine participating centres to the intervention or usual care group. We expect to include 140 adult cancer patients receiving first-line systemic anticancer treatment. Trained nurses at the intervention clusters will provide at least two semistructured consultations with the involvement of SN©Flyers. Outcomes include patients’ accrual and retention rates, patient-reported interference of symptoms with daily functions, symptom burden, perceived self-efficacy, quality of nursing care, nurse-reported facilitators and barriers of adopting the programme, nurses’ fidelity of providing the intervention as intended, and patients’ safety (patients timely reporting of severe symptoms). We will use validated questionnaires for patient-reported outcomes, focus group interviews with nurses and individual interviews with oncologists. Linear mixed models will be used to analyse patient-reported outcomes. Focus group and individual interviews will be analysed by thematic analysis.Ethics and disseminationThe Symptom Navi© Pilot Study has been reviewed and approved by Swiss Ethic Committee Bern (KEK-BE: 2017–00020). Results of the study will be disseminated in peer-reviewed journal and at scientific conferences.Trial registration numberNCT03649984; Pre-results.

show abstract

Does depression decrease the moderating effect of self‐efficacy in the relationship between illness perception and fear of progression in breast cancer?

Cited by 25 publications

References 39 publications

Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross‐sectional study

Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross‐sectional study

Predictors of the Worry About Cancer Recurrence Among Women With Breast Cancer

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Contact Info

Product

Resources

About